Marianne D Sadar

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

International journal of molecular sciences

Organic letters

Cancers

Expert opinion on drug discovery

University of British Columbia

University of Bradford (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of British Columbia

Canada

Full Professor (current rank) :: Pathology and Laboratory Medicine

BC Cancer Agency

Canada

Distinguished Scientist (current rank) :: Genome Sciences Centre

Education History

University of Bradford

United Kingdom

PHD :: Biochemistry

Simon Fraser University

Canada

BSC :: Biochemistry

Publications

Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Amy H Tien, Marianne D Sadar
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer. International journal of molecular sciences 25 (3) (2024)
Mostafa Hagar, Kalindi D Morgan, Spencer D Stumpf, Maya Tsingos, Carmen A Banuelos, Marianne D Sadar, Joshua A V Blodgett, Raymond J Andersen, Katherine S Ryan
Piperazate-Guided Isolation of Caveamides A and B, Cyclohexenylalanine-Containing Nonribosomal Peptides from a Cave Actinomycete. Organic letters 26 (19) (2024)
Mostafa Hagar, Kalindi D Morgan, Spencer D Stumpf, Maya Tsingos, Carmen A Banuelos, Marianne D Sadar, Joshua A V Blodgett, Raymond J Andersen, Katherine S Ryan
Piperazate-Guided Isolation of Caveamides A and B, Cyclohexenylalanine-Containing Nonribosomal Peptides from a Cave Actinomycete. Organic letters (2024)
Shaon Basu, Paula Martínez-Cristóbal, Marta Frigolé-Vivas, Mireia Pesarrodona, Michael Lewis, Elzbieta Szulc, C Adriana Bañuelos, Carolina Sánchez-Zarzalejo, Stasė Bielskutė, Jiaqi Zhu, Karina Pombo-García, Carla Garcia-Cabau, Levente Zodi, Hannes Dockx, Jordann Smak, Harpreet Kaur, Cristina Batlle, Borja Mateos, Mateusz Biesaga, Albert Escobedo, Lídia Bardia, Xavier Verdaguer, Alessandro Ruffoni, Nasrin R Mawji, Jun Wang, Jon K Obst, Teresa Tam, Isabelle Brun Heath, Salvador Ventura, David Meierhofer, Jesús García, Paul Robustelli, Travis H Stracker, Marianne D Sadar, Antoni Riera, Denes Hnisz, Xavier Salvatella
Rational optimization of a transcription factor activation domain inhibitor. Nature structural & molecular biology (2023)
Jon K Obst, Nasrin R Mawji, Simon J L Teskey, Jun Wang, Marianne D Sadar
Differential Gene Expression Profiles between N-Terminal Domain and Ligand-Binding Domain Inhibitors of Androgen Receptor Reveal Ralaniten Induction of Metallothionein by a Mechanism Dependent on MTF1. Cancers 14 (2) (2022)
Jacky K Leung, Yusuke Imamura, Minoru Kato, Jun Wang, Nasrin R Mawji, Marianne D Sadar
Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor. Communications biology 4 (1) (2021)
Amy H Tien, Marianne D Sadar
Cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with ralaniten analogues for the treatment of androgen receptor-positive prostate and breast cancers. Molecular cancer therapeutics (2021)
Kalindi D Morgan, David E Williams, Brian O Patrick, Marion Remigy, Carmen A Banuelos, Marianne D Sadar, Katherine S Ryan, Raymond J Andersen
Incarnatapeptins A and B, Nonribosomal Peptides Discovered Using Genome Mining and 1H/15N HSQC-TOCSY. Organic letters 22 (11) (2020)
Yukiyoshi Hirayama, Teresa Tam, Kunzhong Jian, Raymond J Andersen, Marianne D Sadar
Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer. Molecular oncology 14 (10) (2020)
Carmen A Banuelos, Yusuke Ito, Jon K Obst, Nasrin R Mawji, Jun Wang, Yukiyoshi Hirayama, Jacky K Leung, Teresa Tam, Amy H Tien, Raymond J Andersen, Marianne D Sadar
Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants. Cancers 12 (7) (2020)
Marianne D Sadar
Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor. Expert opinion on drug discovery 15 (5) (2020)
Luping Yan, Carmen A Banuelos, Nasrin R Mawji, Brian O Patrick, Marianne D Sadar, Raymond J Andersen
Structure-Activity Relationships for the Marine Natural Product Sintokamides: Androgen Receptor N-Terminus Antagonists of Interest for Treatment of Metastatic Castration-Resistant Prostate Cancer. Journal of natural products 84 (3) (2020)
Jacky K Leung, Teresa Tam, Jun Wang, Marianne D Sadar
Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones. Human cell 34 (1) (2020)

Marianne D Sadar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marianne D Sadar